TWI759076B - Medicine delivery device for healing body cavity wound and medicine delivery duct thereof - Google Patents

Medicine delivery device for healing body cavity wound and medicine delivery duct thereof Download PDF

Info

Publication number
TWI759076B
TWI759076B TW110101675A TW110101675A TWI759076B TW I759076 B TWI759076 B TW I759076B TW 110101675 A TW110101675 A TW 110101675A TW 110101675 A TW110101675 A TW 110101675A TW I759076 B TWI759076 B TW I759076B
Authority
TW
Taiwan
Prior art keywords
pipe
medicine
tube
electrostatic discharge
section
Prior art date
Application number
TW110101675A
Other languages
Chinese (zh)
Other versions
TW202228811A (en
Inventor
陳映臻
林詮斌
Original Assignee
陳映臻
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 陳映臻 filed Critical 陳映臻
Priority to TW110101675A priority Critical patent/TWI759076B/en
Application granted granted Critical
Publication of TWI759076B publication Critical patent/TWI759076B/en
Publication of TW202228811A publication Critical patent/TW202228811A/en

Links

Images

Abstract

The present invention relates to a medicine delivery device for healing body cavity wound and a medicine delivery duct thereof, which are adapted to an endoscope. The medicine delivery duct includes an inner pipe and an electrostatic discharge pipe. The inner pipe has an inserting section and an exposing section, wherein the inserting section is inserted into the endoscope, and the electrostatic discharge pipe is sleeved on the exposing section. The medicine delivery device further includes: a control valve having a pipe connecting end connected to the exposing section of the inner pipe, a medicine entry end, and a positive-pressure air inlet end; a medicine supplying duct connected to the medicine entry end; a first air supply unit connected to the medicine supplying duct; an air inlet pipe connected to the positive-pressure air inlet end; a second air supply unit connected to the air inlet pipe; a processing unit configured for selectively controlling the pipe connecting end to communicate with the medicine entry end or the positive-pressure air inlet end, and for controlling the first or second air supply unit to supply air.

Description

治療內腔室傷口之藥劑推進裝置及其藥劑推進管 Medicine propelling device and medicine propelling tube for treating wound in inner chamber

本發明係有關於一種治療內腔室傷口之藥劑推進裝置及其藥劑推進管,特別是指能夠消除藥劑推進管的靜電,避免使用粉狀的藥劑時受靜電吸附而使藥劑堵塞在藥劑推進管的發明。 The present invention relates to a medicament propelling device and its medicament propelling tube for treating wounds in an inner chamber, in particular, it can eliminate the static electricity of the medicament propelling tube, and avoid the medicament being blocked in the medicament propelling tube by electrostatic adsorption when using powdered medicament 's invention.

內視鏡是用來檢查人體諸如胃臟、膀胱等內腔室內的疾患的有力工具。 Endoscopy is a powerful tool used to examine diseases in the inner chambers of the human body such as the stomach and bladder.

傳統內視鏡僅有觀察檢視的功能,當發現內腔室內的疾患時,需要取出內視鏡後由醫師評估後續的處置。由於內視鏡是一種侵入性的檢查,且對於內腔室內的疾患通常也需要進行侵入性的處置,進行多次侵入性的檢查及處置不僅造成患者的不舒適,也增加感染的風險。 The traditional endoscope only has the function of observation and inspection. When diseases in the inner chamber are found, the doctor needs to evaluate the follow-up treatment after removing the endoscope. Since endoscopy is an invasive examination, and invasive treatment is usually required for diseases in the inner chamber, multiple invasive examinations and treatments not only cause discomfort to the patient, but also increase the risk of infection.

因此,目前的內視鏡通常附加有可以剃除息肉的刀具,或者附加可以對潰瘍等傷口進行給藥的給藥導管等處置器具,期望對於疾患的檢測及處置可以一次完成,以減少患者的不舒適,也降低感染的風險。 Therefore, the current endoscope is usually attached with a knife that can shave polyps, or a treatment device such as a drug delivery catheter that can administer drugs to wounds such as ulcers. Uncomfortable and also reduces the risk of infection.

而對於內視鏡給藥的裝置中,發明人發現用於給藥的給藥導管一般是由鐵氟龍塑膠製成,此種塑膠導管會在導管表面具有極高的靜電,雖然給藥導管伸入內視鏡中的部分會因為內視鏡的金屬網使靜電被釋放,但外露於內視鏡外的部分由於仍然有一定的長度,當所需給藥之藥劑為粉劑時,時常因為 靜電吸附的現象導致藥劑堵塞在給藥導管外露於內視鏡的部分,發明人實際測試發現給藥導管中的靜電可高達13000V至23000V之間。 As for the device for endoscopic drug delivery, the inventor found that the drug delivery catheter used for drug delivery is generally made of Teflon plastic. This plastic catheter will have extremely high static electricity on the surface of the catheter. The part that protrudes into the endoscope will be discharged due to the metal mesh of the endoscope, but the part exposed outside the endoscope still has a certain length. When the medicine to be administered is powder, it is often caused by The phenomenon of electrostatic adsorption causes the drug to be blocked in the part of the drug delivery catheter exposed to the endoscope. The inventor's actual test found that the static electricity in the drug delivery catheter can be as high as 13000V to 23000V.

爰此,本發明提出一種治療內腔室傷口之藥劑推進裝置及其藥劑推進管,用以結合一內視鏡使用。 Therefore, the present invention provides a medicine propelling device for treating wounds in an inner chamber and a medicine propelling tube thereof, which are used in combination with an endoscope.

該藥劑推進管包括有一內管及一靜電洩放管,該內管有一伸入段及一外露段,該伸入段伸入前述內視鏡中,該靜電洩放管套在該外露段的至少一部份,該靜電洩放管套在該內管的外露段的部分係自該內管的外露段與該控制閥連接處起算,佔該外露段的80%長度。該藥劑推進裝置還包括有:一控制閥,有一管接端、一進藥端及一正壓進氣端,可選擇地控制該管接端與該進藥端相連通,或控制該管接端與該正壓進氣端相連通,該管接端連接該內管之外露段;一藥劑供應管,連接該進藥端;一第一供氣單元,連接該藥劑供應管;一進氣管,連接該正壓進氣端;一第二供氣單元,連接該進氣管;一處理器,電性連接該控制閥、該第一供氣單元及該第二供氣單元。除此之外,在該藥劑推進裝置中,亦可透過一三通閥連接該藥劑供應管及該進氣管,以及以單一個供氣單元連接該三通閥,並藉由控制該三通閥連通該供氣單元與該藥劑供應管,或連通該供氣單元與該進氣管來進行選擇式地供氣。 The medicine propelling tube includes an inner tube and an electrostatic discharge tube. The inner tube has a protruding section and an exposed section. The protruding section protrudes into the endoscope, and the electrostatic discharge tube is sleeved on the exposed section. At least a part of the electrostatic discharge pipe sleeved on the exposed section of the inner tube is 80% of the length of the exposed section calculated from the connection between the exposed section of the inner tube and the control valve. The medicine propelling device also includes: a control valve, which has a pipe connection end, a medicine inlet end and a positive pressure inlet end, which can selectively control the connection between the pipe connection end and the medicine inlet end, or control the pipe connection end to communicate with the medicine inlet end. The end is communicated with the positive pressure inlet end, the pipe connection end is connected to the outer exposed section of the inner tube; a medicine supply pipe is connected to the medicine inlet end; a first air supply unit is connected to the medicine supply pipe; an air inlet A pipe is connected to the positive pressure air inlet end; a second air supply unit is connected to the air intake pipe; a processor is electrically connected to the control valve, the first air supply unit and the second air supply unit. In addition, in the medicine propelling device, the medicine supply pipe and the air intake pipe can also be connected through a three-way valve, and a single air supply unit can be connected to the three-way valve, and the three-way valve can be controlled by controlling the three-way valve. The valve communicates the air supply unit and the medicine supply pipe, or communicates the air supply unit and the air intake pipe to selectively supply air.

進一步,該靜電洩放管為靜電可導通材質。 Further, the electrostatic discharge tube is made of electrostatically conductive material.

進一步,該靜電洩放管有一接地端。 Further, the electrostatic discharge tube has a grounding end.

進一步,該控制閥的管接端包括有錐形的一套管,以及一固定環鎖固在該套管外。 Further, the pipe connection end of the control valve includes a conical sleeve, and a fixing ring is locked outside the sleeve.

透過上述技術特徵可達成以下功效: Through the above technical features, the following effects can be achieved:

1.本發明透過在藥劑推進管之內管的外露段套設有靜電洩放管,可避免粉狀藥劑在給藥時,受到靜電吸附造成堵塞的問題。而自該內管的外露段與該控制閥連接處起算,該靜電洩放管套在該內管的外露段的部分佔該外露段的80%長度,可以有效克服靜電吸附的問題。 1. The present invention can avoid the problem of blockage caused by electrostatic adsorption of the powdered medicament during administration by covering the exposed section of the inner tube of the medicament propelling tube with an electrostatic discharge tube. From the connection between the exposed section of the inner tube and the control valve, the portion of the electrostatic discharge tube sleeved on the exposed section of the inner tube accounts for 80% of the length of the exposed section, which can effectively overcome the problem of electrostatic adsorption.

2.本發明透過該處理器選擇地控制該控制閥的該管接端與該進藥端相連通或控制該管接端與該正壓進氣端相連通。在該管接端與該進藥端相連通時持續進行給藥;而在停止給藥時,使該管接端與該正壓進氣端相連通,並通入氣體,維持該藥劑推進管之內管的正壓,避免內腔室內的藥劑、血液回流造成該藥劑推進管的內管堵塞。 2. In the present invention, the processor selectively controls the pipe connection end of the control valve to communicate with the drug inlet end or controls the pipe connection end to communicate with the positive pressure inlet end. When the pipe connection end is communicated with the drug inlet end, the drug administration is continued; and when the drug administration is stopped, the pipe connection end is communicated with the positive pressure intake end, and gas is introduced to maintain the drug propelling tube The positive pressure of the inner tube can prevent the inner tube of the medicine propelling tube from being blocked due to the backflow of the medicine and blood in the inner chamber.

1:藥劑推進管 1: Pharmacy push tube

11:內管 11: Inner tube

111:伸入段 111: Reach into the segment

112:外露段 112: Exposed segment

12:靜電洩放管 12: Static discharge tube

121:接地端 121: ground terminal

2:控制閥 2: Control valve

21:管接端 21: Pipe end

211:套管 211: Casing

212:固定環 212: Retaining ring

22:進藥端 22: Into the medicine end

23:正壓進氣端 23: Positive pressure intake end

3:藥劑供應管 3: Pharmacy supply pipe

4:第一供氣單元 4: The first air supply unit

5:進氣管 5: Intake pipe

6:第二供氣單元 6: The second air supply unit

7:處理器 7: Processor

8:內視鏡 8: Endoscope

81:通道 81: Channel

9:三通閥 9: Three-way valve

10:供氣單元 10: Air supply unit

[第一圖]係為本發明實施例中,藥劑推進裝置的分解圖。 [Figure 1] is an exploded view of the medicine propelling device in the embodiment of the present invention.

[第二圖]係為本發明實施例中,藥劑推進裝置的組合圖。 [The second figure] is a combined drawing of the medicine propelling device in the embodiment of the present invention.

[第三圖]係為本發明實施例中,控制閥的管接端連接固定藥劑推進管的內管的示意圖。 [Fig. 3] is a schematic diagram of the pipe joint end of the control valve connected to the inner pipe of the fixed medicine propelling pipe in the embodiment of the present invention.

[第四圖]係為本發明實施例中,利用藥劑推進裝置進行給藥的流程圖。 [FIG. 4] is a flow chart of drug delivery using a drug propelling device in an embodiment of the present invention.

[第五圖]係為本發明另一實施例之藥劑推進裝置的示意圖。 [Fig. 5] is a schematic diagram of a medicine propelling device according to another embodiment of the present invention.

綜合上述技術特徵,本發明治療內腔室傷口之藥劑推進裝置及其藥劑推進管的主要功效將可於下述實施例清楚呈現。 In view of the above technical features, the main functions of the medicine propelling device and its medicine propelling tube for treating an inner cavity wound of the present invention will be clearly presented in the following embodiments.

參閱第一圖及第二圖所示,本實施例之藥劑推進裝置包括: 一藥劑推進管1,有一內管11及一靜電洩放管12,該內管11有一伸入段111及一外露段112,該靜電洩放管12套在該外露段112的至少一部份,本實施例該靜電洩放管12之材質使用靜電可導通材質,且該靜電洩放管12有一接地端121。一控制閥2,有一管接端21、一進藥端22及一正壓進氣端23,該管接端21連接該內管11之外露段112,該靜電洩放管12套在該內管11的外露段112的部分係自該內管11的外露段112與該控制閥2連接處起算,佔該外露段112的80%長度。一藥劑供應管3,連接該進藥端22。一第一供氣單元4,連接該藥劑供應管3。一進氣管5,連接該正壓進氣端23。一第二供氣單元6,連接該進氣管5。一處理器7,電性連接該控制閥2、該第一供氣單元4及該第二供氣單元6。 Referring to the first and second figures, the medicine propelling device of this embodiment includes: A medicine propelling tube 1 has an inner tube 11 and an electrostatic discharge tube 12 , the inner tube 11 has a protruding section 111 and an exposed section 112 , and the electrostatic discharge tube 12 is sheathed at least a part of the exposed section 112 In this embodiment, the electrostatic discharge tube 12 is made of an electrostatically conductive material, and the electrostatic discharge tube 12 has a grounding end 121 . A control valve 2 has a pipe connection end 21, a medicine inlet end 22 and a positive pressure air inlet end 23. The pipe connection end 21 is connected to the outer exposed section 112 of the inner pipe 11, and the electrostatic discharge pipe 12 is sleeved in the inner pipe. The part of the exposed section 112 of the pipe 11 is counted from the connection between the exposed section 112 of the inner pipe 11 and the control valve 2 , and accounts for 80% of the length of the exposed section 112 . A medicine supply pipe 3 is connected to the medicine feeding end 22 . A first air supply unit 4 is connected to the medicine supply pipe 3 . An intake pipe 5 is connected to the positive pressure intake end 23 . A second air supply unit 6 is connected to the air intake pipe 5 . A processor 7 is electrically connected to the control valve 2 , the first air supply unit 4 and the second air supply unit 6 .

參閱第三圖所示,為了將該內管11之外露段112穩固的套接在該控制閥2的管接端21,該管接端21可包括有錐形的一套管211,以及一固定環212鎖固在該套管211外,先將該內管11之外露段112套設在該套管211上,藉由錐形的套管211,使該外露段112的端部擴張變形而卡固在該套管211上,之後將該固定環212鎖固在該套管211外而固定該內管11之外露段112。 Referring to Fig. 3, in order to securely sleeve the exposed section 112 of the inner pipe 11 on the pipe connection end 21 of the control valve 2, the pipe connection end 21 may include a conical sleeve 211, and a The fixing ring 212 is locked outside the sleeve 211 , and the exposed section 112 of the inner tube 11 is first sleeved on the sleeve 211 , and the end of the exposed section 112 is expanded and deformed by the tapered sleeve 211 . The fixing ring 212 is then locked on the sleeve 211 to fix the exposed section 112 of the inner tube 11 .

參閱第一圖及第二圖所示,該藥劑推進管1於醫師使用一內視鏡8觀察病患之內腔室而發現例如潰瘍等需要給藥之疾患時,可使該內管11之伸入段111伸入前述內視鏡8之一通道81,並自該內視鏡8的前端伸出,以對該內腔室的疾患給藥。 Referring to the first and second figures, when the physician uses an endoscope 8 to observe the patient's inner chamber and finds diseases such as ulcers that require medication, the inner tube 11 can be pushed forward. The protruding section 111 protrudes into a channel 81 of the aforementioned endoscope 8 and protrudes from the front end of the endoscope 8 so as to administer medicine to the disease in the inner chamber.

參閱第一圖、第二圖及第四圖所示,該處理器7可選擇地控制該控制閥2的該管接端21與該進藥端22相連通,或控制該管接端21與該正壓進氣端23相連通。具體而言,要進行給藥時,醫師透過該處理器7控制該管接端21與該進藥端22相連通,並控制該第一供氣單元4啟動,使該藥劑供應管3內的藥劑 可以對該疾患持續給藥,由於該內管11的外露段112套設有該靜電洩放管12,因此可避免粉狀藥劑在給藥時,受到該內管11的靜電吸附造成堵塞在該內管11的問題,而自該內管11的外露段112與該控制閥2連接處起算,該靜電洩放管12套在該內管11的外露段112的部分佔該外露段112的80%長度,可以有效克服靜電吸附的問題,確保藥劑可以有效到達該疾患;當醫師評估藥劑用量足夠時,可透過該處理器7關閉該第一供氣單元4,使該藥劑供應管3停止給藥,此時再透過該處理器7控制該管接端21與該正壓進氣端23相連通,並控制該第二供氣單元6啟動而通入氣體,維持該藥劑推進管1之內管11的正壓,藉以將該內管11內殘留的藥劑送至該疾患處,同時可避免內腔室內的藥劑、血液回流至該內管11而造成該內管11堵塞。 Referring to the first, second and fourth figures, the processor 7 can selectively control the pipe connection end 21 of the control valve 2 to communicate with the drug inlet end 22 , or control the pipe connection end 21 to communicate with the drug inlet end 22 . The positive pressure inlet end 23 is communicated with each other. Specifically, when the drug is to be administered, the physician controls the connection between the pipe connection end 21 and the drug inlet end 22 through the processor 7, and controls the activation of the first air supply unit 4, so that the gas in the drug supply pipe 3 is activated. medicine The drug can be continuously administered to the disease. Since the exposed section 112 of the inner tube 11 is sleeved with the electrostatic discharge tube 12, it can prevent the powder medicine from being blocked by the electrostatic adsorption of the inner tube 11 during administration. The problem of the inner tube 11, and starting from the connection between the exposed section 112 of the inner tube 11 and the control valve 2, the portion of the electrostatic discharge tube 12 sleeved on the exposed section 112 of the inner tube 11 accounts for 80% of the exposed section 112. % length, which can effectively overcome the problem of electrostatic adsorption and ensure that the medicine can effectively reach the disease; when the doctor assesses that the dosage of the medicine is sufficient, the first air supply unit 4 can be closed through the processor 7, so that the medicine supply pipe 3 stops supplying the medicine. At this time, the processor 7 controls the pipe connection end 21 to communicate with the positive pressure air inlet end 23, and controls the second air supply unit 6 to start up to introduce gas, so as to maintain the drug push into the tube 1 The positive pressure of the tube 11 is used to send the medicine remaining in the inner tube 11 to the diseased part, and at the same time, it can prevent the medicine and blood in the inner chamber from flowing back to the inner tube 11 and causing the inner tube 11 to be blocked.

參閱第五圖所示,係本發明另一實施例,與前述實施例不同之處在於,在該藥劑推進裝置中,係透過一三通閥9連接該藥劑供應管3及該進氣管5,以及以單一個供氣單元10連接該三通閥9,該處理器7則電性連接該控制閥2、該三通閥9及該供氣單元10,藉由該處理器7控制該三通閥9連通該供氣單元10與該藥劑供應管3,或連通該供氣單元10與該進氣管5來進行選擇式地供氣。因此可使用單一個供氣單元10來達到與前述實施例相同的供氣效果。 Referring to Figure 5, it is another embodiment of the present invention. The difference from the previous embodiment is that in the medicine propelling device, the medicine supply pipe 3 and the air intake pipe 5 are connected through a three-way valve 9 , and a single air supply unit 10 is connected to the three-way valve 9, and the processor 7 is electrically connected to the control valve 2, the three-way valve 9 and the air supply unit 10, and the processor 7 controls the three-way valve 9. The through valve 9 communicates the air supply unit 10 and the medicine supply pipe 3, or communicates the air supply unit 10 and the intake pipe 5 for selective air supply. Therefore, a single air supply unit 10 can be used to achieve the same air supply effect as the previous embodiment.

綜合上述實施例之說明,當可充分瞭解本發明之操作、使用及本發明產生之功效,惟以上所述實施例僅係為本發明之較佳實施例,當不能以此限定本發明實施之範圍,即依本發明申請專利範圍及發明說明內容所作簡單的等效變化與修飾,皆屬本發明涵蓋之範圍內。 Based on the descriptions of the above-mentioned embodiments, one can fully understand the operation, use and effects of the present invention, but the above-mentioned embodiments are only preferred embodiments of the present invention, which should not limit the implementation of the present invention. Scope, that is, simple equivalent changes and modifications made according to the scope of the patent application of the present invention and the contents of the description of the invention, all fall within the scope of the present invention.

1:藥劑推進管 1: Pharmacy push tube

11:內管 11: Inner tube

111:伸入段 111: Reach into the segment

112:外露段 112: Exposed segment

12:靜電洩放管 12: Static discharge tube

121:接地端 121: ground terminal

2:控制閥 2: Control valve

21:管接端 21: Pipe end

22:進藥端 22: Into the medicine end

23:正壓進氣端 23: Positive pressure intake end

3:藥劑供應管 3: Pharmacy supply pipe

4:第一供氣單元 4: The first air supply unit

5:進氣管 5: Intake pipe

6:第二供氣單元 6: The second air supply unit

7:處理器 7: Processor

8:內視鏡 8: Endoscope

81:通道 81: Channel

Claims (9)

一種治療內腔室傷口之藥劑推進管,用以伸入一內視鏡中,包括有:一內管,有一伸入段及一外露段,該伸入段伸入前述內視鏡中;一靜電洩放管,套在該內管的外露段的至少一部份,該靜電洩放管套在該外露段的部分係自靠近該內管的端部起算,佔該外露段的80%長度。 A medicament advancing tube for treating wounds in an inner chamber, used for extending into an endoscope, comprising: an inner tube, an extending section and an exposed section, the extending section extending into the endoscope; a An electrostatic discharge tube, which is sleeved on at least a part of the exposed section of the inner tube, and the part of the electrostatic discharge tube sleeved in the exposed section is counted from the end close to the inner tube, accounting for 80% of the length of the exposed section . 如請求項1之治療內腔室傷口之藥劑推進管,其中,該靜電洩放管為靜電可導通材質。 As claimed in claim 1, the medicament propelling tube for treating wounds in an inner chamber, wherein the electrostatic discharge tube is made of electrostatically conductive material. 如請求項1之治療內腔室傷口之藥劑推進管,其中,該靜電洩放管有一接地端。 The medicament propelling tube for treating wounds in an inner chamber as claimed in claim 1, wherein the electrostatic discharge tube has a grounding end. 一種治療內腔室傷口之藥劑推進裝置,用以結合一內視鏡使用,包括:一藥劑推進管,有一內管及一靜電洩放管,該內管有一伸入段及一外露段,該伸入段伸入前述內視鏡中,該靜電洩放管套在該外露段的至少一部份;一控制閥,有一管接端、一進藥端及一正壓進氣端,可選擇地控制該管接端與該進藥端相連通,或控制該管接端與該正壓進氣端相連通,該管接端連接該內管之外露段;一藥劑供應管,連接該進藥端;一第一供氣單元,連接該藥劑供應管;一進氣管,連接該正壓進氣端;一第二供氣單元,連接該進氣管;一處理器,電性連接該控制閥、該第一供氣單元及該第二供氣單元。 A medicament propelling device for treating wounds in an inner chamber is used in combination with an endoscope, comprising: a medicament propelling tube, an inner tube and an electrostatic discharge tube, the inner tube has an extending section and an exposing section, the The protruding section extends into the aforementioned endoscope, and the electrostatic discharge tube is sleeved on at least a part of the exposed section; a control valve has a pipe connection end, a drug inlet end and a positive pressure air inlet end, which can be selected Control the pipe connection end to communicate with the medicine inlet end, or control the pipe connection end to communicate with the positive pressure inlet end, the pipe connection end is connected to the exposed section of the inner pipe; a medicine supply pipe is connected to the inlet a medicine end; a first air supply unit, connected to the medicine supply pipe; an air inlet pipe, connected to the positive pressure air inlet; a second air supply unit, connected to the air inlet pipe; a processor, electrically connected to the a control valve, the first air supply unit and the second air supply unit. 如請求項4之治療內腔室傷口之藥劑推進裝置,其中,該靜電洩放管套在該內管的外露段的部分係自該內管的外露段與該控制閥連接處起算,佔該外露段的80%長度。 The drug propelling device for treating wounds in an inner chamber as claimed in claim 4, wherein the portion of the electrostatic discharge tube sleeved on the exposed section of the inner tube is counted from the connection between the exposed section of the inner tube and the control valve, accounting for the 80% of the length of the exposed section. 如請求項4之治療內腔室傷口之藥劑推進裝置,其中,該靜電洩放管為靜電可導通材質。 As claimed in claim 4, the medicament propelling device for treating wounds in an inner chamber, wherein the electrostatic discharge tube is made of electrostatically conductive material. 如請求項4之治療內腔室傷口之藥劑推進裝置,其中,該靜電洩放管有一接地端。 The medicament propelling device for treating wounds in an inner chamber as claimed in claim 4, wherein the electrostatic discharge tube has a grounding end. 如請求項4之治療內腔室傷口之藥劑推進裝置,其中,該控制閥的管接端包括有錐形的一套管,以及一固定環鎖固在該套管外。 The medicament propelling device for treating wounds in an inner chamber as claimed in claim 4, wherein the pipe connection end of the control valve comprises a conical sleeve, and a fixing ring is locked outside the sleeve. 一種治療內腔室傷口之藥劑推進裝置,用以結合一內視鏡使用,包括:一藥劑推進管,有一內管及一靜電洩放管,該內管有一伸入段及一外露段,該伸入段伸入前述內視鏡中,該靜電洩放管套在該外露段的至少一部份;一控制閥,有一管接端、一進藥端及一正壓進氣端,可選擇地控制該管接端與該進藥端相連通,或控制該管接端與該正壓進氣端相連通,該管接端連接該內管之外露段;一藥劑供應管,連接該進藥端;一進氣管,連接該正壓進氣端;一三通閥,連接該藥劑供應管及該進氣管;一供氣單元,連接該三通閥;一處理器,電性連接該控制閥、該三通閥及該供氣單元。 A medicament propelling device for treating wounds in an inner chamber is used in combination with an endoscope, comprising: a medicament propelling tube, an inner tube and an electrostatic discharge tube, the inner tube has an extending section and an exposing section, the The protruding section extends into the aforementioned endoscope, and the electrostatic discharge tube is sleeved on at least a part of the exposed section; a control valve has a pipe connection end, a drug inlet end and a positive pressure air inlet end, which can be selected Control the pipe connection end to communicate with the medicine inlet end, or control the pipe connection end to communicate with the positive pressure inlet end, the pipe connection end is connected to the exposed section of the inner pipe; a medicine supply pipe is connected to the inlet A medicine end; an air inlet pipe, connected to the positive pressure air inlet; a three-way valve, connected to the medicine supply pipe and the air inlet pipe; an air supply unit, connected to the three-way valve; a processor, electrically connected The control valve, the three-way valve and the air supply unit.
TW110101675A 2021-01-15 2021-01-15 Medicine delivery device for healing body cavity wound and medicine delivery duct thereof TWI759076B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW110101675A TWI759076B (en) 2021-01-15 2021-01-15 Medicine delivery device for healing body cavity wound and medicine delivery duct thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW110101675A TWI759076B (en) 2021-01-15 2021-01-15 Medicine delivery device for healing body cavity wound and medicine delivery duct thereof

Publications (2)

Publication Number Publication Date
TWI759076B true TWI759076B (en) 2022-03-21
TW202228811A TW202228811A (en) 2022-08-01

Family

ID=81710847

Family Applications (1)

Application Number Title Priority Date Filing Date
TW110101675A TWI759076B (en) 2021-01-15 2021-01-15 Medicine delivery device for healing body cavity wound and medicine delivery duct thereof

Country Status (1)

Country Link
TW (1) TWI759076B (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1728462A2 (en) * 2005-05-30 2006-12-06 Olympus Corporation Instrument for endoscope and instrument system for endoscope
US20090076319A1 (en) * 2007-09-18 2009-03-19 Yuta Muyari Endoscopic-use treatment instrument
CN109200445A (en) * 2018-08-29 2019-01-15 温州生物材料与工程研究所 A kind of suck-back-prevention type chemical spraying device that cooperation endoscope uses
TW201909949A (en) * 2017-07-31 2019-03-16 美商艾克斯公司 Steerable medical device with woven structure and preparation method thereof
WO2020009102A1 (en) * 2018-07-02 2020-01-09 ニプロ株式会社 Device for injecting medical powder inside a body

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1728462A2 (en) * 2005-05-30 2006-12-06 Olympus Corporation Instrument for endoscope and instrument system for endoscope
US20090076319A1 (en) * 2007-09-18 2009-03-19 Yuta Muyari Endoscopic-use treatment instrument
TW201909949A (en) * 2017-07-31 2019-03-16 美商艾克斯公司 Steerable medical device with woven structure and preparation method thereof
WO2020009102A1 (en) * 2018-07-02 2020-01-09 ニプロ株式会社 Device for injecting medical powder inside a body
CN109200445A (en) * 2018-08-29 2019-01-15 温州生物材料与工程研究所 A kind of suck-back-prevention type chemical spraying device that cooperation endoscope uses

Also Published As

Publication number Publication date
TW202228811A (en) 2022-08-01

Similar Documents

Publication Publication Date Title
CN102019028B (en) In-vivo dry powder conveying device and implementation method thereof
US9205207B2 (en) Internal dry powder delivery system and method thereof
US4969878A (en) Thick-walled flexible probe for insertion in the trachea or respectively in the bronchial system
US5318517A (en) Multiple lumen thoracostomy catheter and method for administering anesthesia
RU84711U1 (en) NOBILE CATHETER-DRAINAGE
US11229447B2 (en) Systems, instruments and methods for treating sinuses
TWI653066B (en) Tracheal tube system including tracheal tube and suction device
US9795770B1 (en) Bendable nasal airway tube device and method of bending same
TWI759076B (en) Medicine delivery device for healing body cavity wound and medicine delivery duct thereof
TWM614985U (en) Medicament advancing device for treating wound of inner cavity and medicine advancing tube thereof
EP4011418A1 (en) Device for controlled administration of a liquid solution to nasal cavities and paranasal sinuses
CN106492317B (en) A kind of medical atomized drug delivery device
JP2022512368A (en) Assembly for delivering the drug
CN114870225B (en) Device for temporarily filling and administering medicine through nasopharyngeal tube
EP1039861A1 (en) Medical device for internal heat treatment and drug delivery
CN112933380B (en) Dual anorectal drug delivery device
CN220142413U (en) Anorectal drug delivery device
JP2021513450A (en) Ear catheter
CN216258697U (en) Novel gynaecology is with regional vagina of target device of dosing
CN219090788U (en) Simple and easy adult external auditory canal deep and tympanic membrane surface drug delivery device
US20210205548A1 (en) Agent delivery systems and methods of using the same
JP4351562B2 (en) Insertion tube
CN115487404A (en) Digestive tract shaping device
CN110464970A (en) The accurate drug delivery device in nasal cavity olfactory cleft area
CN117580606A (en) Multi-lumen catheter